Blue%20Bag%20with%20Cross%20Icon%20Medic

INVESTOR RELATIONS

(TSXV:VPT, OTC:VPTDF)

Ventripoint Diagnostics Ltd is a medical device company that is primarily engaged in the development and commercialization of cardiac diagnostic tools.  It sells its products worldwide.
CAPITAL STRUCTURE

Symbol:    TSX-V: VPT    &    OTC: VPTDF

Shares Outstanding       127M

Shares Fully Diluted      148M

Recent Share Price        CDN$.32

52-Week Range              CDN$.07-.325

Market Cap                      ca. CDN$40M

Insider Ownership (FD)  6%

Public Float Ownership  94%

Debt                                  None

Cash                                 2 years

Liquidity                           CDN$600,000/day

Read full report

KEY AND STRAGETIC GOALS

2020

Ventripoint has entered into a collaboration with the Veterinary Hospital at the North Carolina State University (NCSU) to test and evaluate the use of the VMS+ in echocardiography of canines with the goal of expanding this technology to all animals.

VMS+ could eventually help treat our most loyal best friend.

EXPLORING NEW FRONTIERS FOR VMS+

LATEST FINANCIAL DATA

Quarterly Reports

Annual Reports

LATEST PRESS RELEASES

February 25, 2021

Correction - Ventripoint Diagnostics Issues Shares in Final Payment of
Debenture Interest

LATEST EVENTS

FEB

11

Ventripoint CEO interviewed on TraderTV Live

FEB

04

Ventripoint CEO interviewed by Torrey Hills Capital

INVESTOR RELATIONS TEAM

Clay Chase

Torrey Hills Investor Relations

(858) 456-7300

cc@sdthc.com

Jonathan Robinson

Oak Hill Financial

(416) 669-1001

JRobinson@oakhillfinancial.ca

Adrian Sydenham

MarketSmart Communications Inc.

(877) 261-4466

Info@marketsmart.ca

SUBSCRIBE FOR

2 Sheppard Avenue East, Suite 605

Toronto Ontario M2N 5Y7

Canada

+1-416-848-4156

© 2021 Ventripoint Diagnostics Ltd. All Rights Reserved.

  • Twitter
  • LinkedIn
  • YouTube